Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Cancer Lett. 2023 May 2;565:216207. doi: 10.1016/j.canlet.2023.216207

Table 1.

Oncogenic Substrates of LIMK2: LIMK2 directly phosphorylates TWIST1, SPOP, NKX3.1 and PTEN at multiple sites.

Substrate Role Cancer Phosphorylation Sites Consequence of phosphorylation Consequence on LIMK2
TWIST1 Oncogene CRPC S45, S78, S95, S199 Protein stabilized LIMK2 Stabi ized
SPOP Tumor Suppressor CRPC S59, S171, S226 Protein degraded LIMK2 Degraded
NKX3.1 Tumor Suppressor CRPC S185 Protein degraded LIMK2 Degraded
PTEN Tumor Suppressor CRPC S207, S226, S360, S361, S362 Protein degraded and activity inhibited LIMK2 Degraded